Patrick de Marco, MD
Allergy · Orange Park, FLNPI 1578598967
Payments from drug & device makers
Across 598 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$13K
- Regeneron Healthcare Solutions, Inc.$2K
- CSL Behring$1K
- GSK$1K
- Novartis$978
- Takeda Pharmaceuticals U.S.A., Inc.$675
- plus $5K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 120 | $12,609 |
| Regeneron Healthcare Solutions, Inc. | 59 | $1,651 |
| CSL Behring | 38 | $1,108 |
| GSK | 50 | $1,026 |
| Novartis | 71 | $978 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $675 |
| Optinose US, Inc. | 28 | $642 |
| Sanofi | 24 | $604 |
| Grifols USA, LLC | 42 | $590 |
| Pfizer | 24 | $459 |
| Genentech USA, Inc. | 13 | $396 |
| Alk-abello, Inc | 23 | $333 |
| Octapharma USA, Inc. | 4 | $248 |
| Kaleo, Inc. | 13 | $244 |
| Amgen(2 entities) | 10 | $240 |
| Boehringer Ingelheim | 14 | $225 |
| Pharming Healthcare, Inc. | 11 | $211 |
| Biocryst US Sales Co., LLC | 8 | $173 |
| Sanofi-aventis U.S. LLC | 2 | $124 |
| Lilly USA, LLC | 2 | $56 |
| Merck | 3 | $53 |
| Incyte Corporation | 2 | $53 |
| Biocompatibles, Inc. | 1 | $50 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Blueprint Medicines Corporation | 2 | $42 |
| Eyevance Pharmaceuticals LLC | 2 | $41 |
| Medtronic | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| GC Biopharma USA, Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Circassia Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $15 |
How this compares
$23,054 in reported general payments places this provider in the 85th percentile of 56 allergy providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Orange Park
- Hugh WindomSarasota$3.6M
- Miguel LanzCoral Gables$1.4M
- Brett StanalandNaples$575K
- Alan KoterbaNorth Palm Beach$367K
- David RoseEglin Afb$253K
- Shahid RandhawaFort Lauderdale$91K
- Carlos PiniellaMiami$61K
- Pavana BeerelliRockledge$61K
- Mark MinorMelbourne$21K
- Brian WilsonTallahassee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.